The second was the threshold of CAR-T cell density within the tumor—i.e., the minimum number of CAR-T cells per unit volume required to secrete sufficient anti-VEGF locally to maintain or further the normalization state originally induced by the monoclonal antibody. Here, VEGFA is linked to neoplasm.